OncoCyte (NASDAQ: OCX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of OncoCyte (NASDAQ: OCX) through any online brokerage.
The latest price target for OncoCyte (NASDAQ: OCX) was reported by Stephens & Co. on Tuesday, May 24, 2022. The analyst firm set a price target for 0.00 expecting OCX to fall to within 12 months (a possible -100.00% downside). 10 analyst firms have reported ratings in the last year.
The stock price for OncoCyte (NASDAQ: OCX) is $0.889 last updated July 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for OncoCyte.
OncoCyte’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for OncoCyte.
OncoCyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.